Category Archives: TB

Survey shows Xpert TB diagnosis costly, out of reach in countries where private care predominates

By on .

Patients in the highest tuberculosis-burden countries who primarily rely on the private sector for their healthcare needs do not have access to the GeneXpert MTB/RIF diagnostic test for drug-resistant tuberculosis, according to a new study published in The Lancet. And if they do have access, the people who most need the test can’t afford it. Researchers […]

USAID announces new partnerships to combat MDR-TB at White House plan launch

By on .

At last week’s launch of the National Action Plan for Combating Multidrug-Resistant Tuberculosis, the U.S. Agency for International Development announced expanded partnerships with Janssen, the maker of bedaquiline, the first tuberculosis drug to be produced since the 1950s, and Cepheid, maker of the GeneXpert rapid diagnostic test for drug-resistant tuberculosis. Janssen, the pharmaceutical branch of […]

MDR-TB national action plan raises questions on targets and funding

By on .

After waiting months for the White House’s release of the National Action Plan for Combating Multidrug-Resistant Tuberculosis, TB advocates are asking why the plan isn’t more ambitious (considering some of the plan’s milestones are already close to being reached), and whether the Obama Administration will propose enough funding to put the plan into action. The alternative, they […]